Fact sheet: Polar Capital Healthcare Opp

Fund information

Fund name
Polar Capital Healthcare Opportunities I GBP
Fund company manager
Polar Capital
Fund type
SIB
Fund manager
Daniel Mahony
since 30/11/2007
Fund objective
The Fund aims to preserve capital and achieve long-term growth by investing in a globally-diversified portfolio of companies within the healthcare industry.
Benchmark
MSCI ACWI Health Care Index
Investment style
Active,Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

6.65 %

1 Year rank in sector

16/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.5 b

FE Risk score

141

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    66.22%
  • Money Market
    7.31%
  • Ireland
    6.32%
  • UK
    5.76%
  • Germany
    4.88%
  • Pharmaceuticals
    26%
  • Biotechnology/Medical
    25.87%
  • Healthcare & Medical Products
    24.89%
  • Health Care
    15.93%
  • Money Market
    7.31%
  • US Equities
    66.1%
  • Money Market
    7.4%
  • Irish Equities
    6.3%
  • UK Equities
    5.8%
  • German Equities
    4.9%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-0.07 %1.22 %6.65 %45.51 %173.73 %
Sector4.29 %4.59 %7.67 %20.6 %96.71 %
Rank within sector27 / 3022 / 3016 / 294 / 271 / 23
Quartile th4 th3 rd3 rd1 st1 st

Calendar performance

YTD-20172016201520142013
Fund11.91 %4.59 %13.39 %34.81 %52.86 %
Sector15.62 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector19 / 295 / 297 / 2711 / 247 / 23
Quartile th3 rd1 st2 nd2 nd2 nd

Risk statistics

Alpha10.71
Beta0.7
Sharpe0.84
Volatility14.88
Tracking error11.45
Information ratio0.7
R-Squared0.52

Price movement

52 week high32.74
52 week low26.5
Current bid price0
Current offer price0
Current mid price30.63

Holdings by region

  • 66.22% USA
  • 7.31% Money Market
  • 6.32% Ireland
  • 5.76% UK
  • 4.88% Germany
  • 3.59% France
  • 3.24% Denmark
  • 1.85% Sweden
  • 0.66% Canada
  • 0.19% Netherlands

Holdings by sector

  • 26% Pharmaceuticals
  • 25.87% Biotechnology/Medical
  • 24.89% Healthcare & Medical Products
  • 15.93% Health Care
  • 7.31% Money Market

Holdings by asset type

  • 66.1% US Equities
  • 7.4% Money Market
  • 6.3% Irish Equities
  • 5.8% UK Equities
  • 4.9% German Equities
  • 3.6% French Equities
  • 3.2% Danish Equities
  • 1.8% Swedish Equities
  • 0.7% Canadian Equities
  • 0.2% Dutch Equities

Individual holdings

  • 8.96% JOHNSON & JOHNSON
  • 4.47% ABBOTT LABORATORIES
  • 4.18% CELGENE CORP
  • 3.84% MEDTRONIC PLC
  • 3.62% UNITEDHEALTH GROUP INC
  • 3.59% SANOFI
  • 3.24% GENMAB AS
  • 3.22% FRESENIUS SE & CO KGAA
  • 3.11% ALLERGAN PLC
  • 2.68% KITE PHARMA INC